What is the MTARC1 gene?
Mitochondrial outer-membrane amidoxime-reducing component linked to hepatic lipid handling and liver-enzyme biomarker tendency.
How MTARC1 affects metabolism
When MTARC1-related function is shifted, the practical effect is interpreted through lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.
What happens when MTARC1 is altered
Altered MTARC1 signal should be treated as a DNA-based tendency, not a diagnosis. 1 claim currently passes the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.
Curated SNP evidence for MTARC1
These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.
Evidence-backed report connection
MTARC1 currently has 1 curated SNPs, 1 claim-level scores, and 1 claims eligible for pathway scoring.
Open the sample reportrs2642438MTARC1 Ala165Thr1 claims · 2 study rows
biomarker tendency · A
MTARC1 hepatic lipid and liver-enzyme tendency
rs2642438 A / MTARC1 p.Ala165Thr is associated with lower hepatic lipid and liver-injury biomarker tendency.
MTARC1 rs2642438 A is staged as a hepatic lipid/liver-enzyme protective-tendency allele with reduced-function support.
Show study evidence
Common symptoms people report
- unexpected cholesterol or triglyceride results
- family context around lipid markers
- unclear ApoB, LDL-C, HDL-C, or triglyceride patterns
Biomarkers to validate
ApoB
Shows the number of atherogenic particles more directly than total cholesterol.
LDL-C, HDL-C, and triglycerides
Gives the basic lipid pattern that DNA can help contextualize.
Lp(a) or liver enzymes when relevant
Adds context for inherited lipid risk or liver lipid handling.
Where DNA analysis helps
DNA helps decide whether MTARC1 deserves attention inside the broader Lipids pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.
Example interpretation
MTARC1 may add context to lipoprotein transport, triglyceride-rich particles, LDL clearance, or liver lipid handling, especially when its SNP evidence lines up with other genes in the same pathway.
Suggested validation: ApoB.
What to do next
- Review the Lipids pathway result before interpreting MTARC1 on its own.
- Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
- Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.
Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.
Get My DNA Report